Top Markets
Coin of the day
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Rangering i aksjer #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Aksjekurs
$0.2301
Sist synkronisert: 2026-08-12
Markedsverdi
$228.81K
Endring (1 dag)
-17.82%
Endring (1 år)
95,775.00%
Land
US
Handel The Greater Cannabis Company, Inc. (GCAN)

Kategori

EPS for The Greater Cannabis Company, Inc. (GCAN)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til The Greater Cannabis Company, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for The Greater Cannabis Company, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter